Whitepaper: In-depth look into anti-idiotype antibodies
In this article, Sino Biological will highlight the applications of anti-IDs, and conclude with our two featured case studies on anti-ID development.
List view / Grid view
In this article, Sino Biological will highlight the applications of anti-IDs, and conclude with our two featured case studies on anti-ID development.
In this article, Sino Biological will highlight the design and engineering of bispecific antibodies, and bsAbs expression and production.
A new study led by the Indiana University School of Medicine showed human induced pluripotent stem cells can improve visual acuity, vascular health and other complications related to type 2 diabetes.
A new study has showed how a bioengineered RSV protein vaccine can induce a protective immune response in animal models.
Scientists have found a way to “supercharge” tumour-attacking T cells, which could improve the effectiveness of cell-based cancer immunotherapy and expand the number of cancers it can treat.
New research by UC Riverside may be a crucial step in the design of engineered nano-shells that could serve as vehicles for delivering drugs to specific targets in the body.
Researchers at Texas A&M University have applied organ-on-chip models to the lymph system to create the first lymphangion-chip.
Researchers have discovered a biodegradable nanoparticle that could combat scleroderma, a rare autoimmune disease.
Researchers have discovered two types of cells in the brain that are involved in organising discrete memories based on when they occurred. This finding improves the understanding of how the human brain forms memories and could have implications in memory disorders such as Alzheimer’s disease.
New research by the Salk Institute has shown cellular rejuvenation therapy safely reverses signs of ageing in mice.
In this exclusive Q&A, Dr Paulina Nunez-Badinez, Scientific Researcher at Bayer AG, discusses pre-clinical research of pain related to endometriosis and why there is a lack of research around this area.
A scientist at the University of Houston receives a $2 million grant to innovate computer-aided drug discovery for breast cancer.
Researchers from the Technical University of Munich have successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus enters a cell.
Researchers have developed a new way to generate breast tumour models faster, more reliably and with less immune variability than existing models.
A recent paper highlights how tiny robots with living parts can be designed to effectively deliver drugs to body tissues.